SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul S. who wrote (315)3/30/1998 10:47:00 AM
From: Casey  Read Replies (1) of 1185
 
Paul:

<<Did Maedels not recommend NRT at around the $.90 level. It seems that they know what they are doing and I've heard very good tings about them. Does anyone have information on how to subscribe to Maedels? Do they have a website?>>

Maedel's recommended NRT @ .97 but his buy instruction was to buy up to $1.80 since his instruction came out the day the stock price spiked. He said NRT should quickly go to $3.20. It quicly tanked, and is only now recovering. I have had nothing but very bad experiences with Maedels's picks. His record over the last 18 months is disastrous - and that is being kind.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext